Hello, Guest
Login
Sign Up
 
 

AMEX Stocks in Spotlight: Nevsun Resources, Brigus Gold Corp, Inovio Pharmaceuticals, Navidea Biopharmaceuticals

 
 
Repost This

Lakeway, TX -- (SBWIRE) -- 02/22/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Nevsun Resources (USA)(NYSEAMEX:NSU) went up 3.61% and is trading at $3.73. Nevsun Resources Ltd. (Nevsun) is a gold and base metal mining and exploration company. The Company, through its subsidiaries, is engaged in the acquisition, exploration, development and production of mineral properties. As of December 31, 2011, the Company’s portfolio consisted of the Bisha Property located in Eritrea, North-East Africa with gold, silver and base metal (copper and zinc) mineral resources and mineral reserves.

How Should Investors Trade NSU After The Recent Movement? Find Out Here

Brigus Gold Corp (USA)(NYSEAMEX:BRD) decreased 0.37% and is trading at $0.777. Brigus Gold Corp. (Brigus) is a mining company. The Company is engaged in the extraction, processing, and refining of gold deposits, as well as related activities, including the acquisition, exploration and development of mineral properties principally located in North America. Its sole mining operation is the Black Fox Mine.

Is BRD Strong Buy After The Recent Strong Gains? Get Free Trend Analysis Here

Inovio Pharmaceuticals, Inc.(NYSEAMEX:INO) decreased 2.58% and is trading at $0.692. Inovio Pharmaceuticals, Inc. is engaged in the development of a new generation of vaccines, called synthetic vaccines, focused on cancers and infectious diseases. The Company's SynCon technology enables the design of universal vaccines capable of providing cross-protection against existing or changing strains of pathogens, such as influenza and human immunodeficiency virus (HIV).

Is INO a Buying Opportunity After The Recent Plunge? Don’t Miss Out Our Latest Report Here

Navidea Biopharmaceuticals Inc(NYSEAMEX:NAVB) is up 3.78% and is trading at $3.02. Navidea Biopharmaceuticals, Inc. (Navidea), formerly Neoprobe Corporation, is a biopharmaceutical company focused on the development and commercialization of precision diagnostic agents.

How Should Investors Trade NAVB After The Latest Earnings Report? Find Out Here

About bestdamnpennystocks.com
Best Damn Penny Stocks’ team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.

Disclaimer
The assembled information disseminated by Bestdamnpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Bestdamnpennystocks.com does expect that investors will buy and sell securities based on information assembled and presented in Bestdamnpennystocks.com. PLEASE always do your own due diligence, and consult your financial advisor.